Clinical Trials Browser

Treatment Adherence and Compliance, Breast Neoplasms, Patient Compliance, Treatment Refusal

NCT05122377 2026-01-06

RWE About QOL and Compliance of Patients With OFS in China

Completed

562 enrolled

Breast

Breast Neoplasms, Patient Compliance

NCT06635005 2025-10-16

LIN-BRiCK

Phase NA Recruiting

30 enrolled

Breast

Breast Neoplasms, Patient Compliance

NCT02216162 2025-10-02

PROACTIVE

Phase NA Completed

12 enrolled

Breast

Breast Neoplasms, Patient Compliance

NCT05258539 2025-08-22

AdDePi_KS

Phase NA Active not recruiting

189 enrolled

Breast

Breast Neoplasms, Patient Compliance

NCT01273610 2025-06-10

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

Phase 2 Active not recruiting

40 enrolled 15 charts

Breast

Breast Neoplasms, Patient Compliance

NCT04142476 2025-02-17

HORMONOVILLE

Phase NA Terminated

105 enrolled

Breast

Breast Neoplasms, Patient Compliance

NCT04176809 2021-06-01

COMPLIANCE

Phase NA Unknown

342 enrolled

Breast

Breast Neoplasms, Patient Compliance

NCT01184066 2018-08-31

ACTS

Phase NA Completed

141 enrolled

Breast

Breast Neoplasms, Communication, Patient Compliance

NCT02300675 2017-09-14

PEPs HORMONO

Phase NA Completed

352 enrolled

Breast

Empowerment, Breast Neoplasms, Patient Compliance

NCT01332032 2015-06-01

Promoting Breast Cancer Screening in Non-adherent Women

Completed

36,348 enrolled

Breast

Breast Neoplasms, Patient Compliance

Clinical Trials

Culturally Aware AET Non-Initiation Intervention

RWE About QOL and Compliance of Patients With OFS in China

LIN-BRiCK

PROACTIVE

AdDePi_KS

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

HORMONOVILLE

COMPLIANCE

ACTS

PEPs HORMONO

Promoting Breast Cancer Screening in Non-adherent Women